Chikungunya Arthritis in the Americas
A Pilot Study of the Pathogenesis of Chikungunya Arthritis in the Americas
Sponsor: Allied Research Society
Listed as NCT02463968, this observational or N/A phase trial focuses on Arthritis and Chikungunya and remains completed. Sponsored by Allied Research Society, it has been updated 13 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Feb 2025 — Present [monthly]
Completed
-
Sep 2024 — Feb 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jul 2017 — Aug 2017 [monthly]
Completed NA
Status: Not Yet Recruiting → Completed
-
Jan 2017 — Jul 2017 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Allied Research Society
- Broad Institute of MIT and Harvard
- George Washington University
- Global Disease Research
- US Army Medical Research Institute of Infectious Diseases
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.